In earlier years I had the unique opportunity to work in blindness prevention programs worldwide with an international non-governmental organization, Project ORBIS, Inc., which was in its formative ...

Rates of cataract formation and extraction after Descemet’s stripping endothelial keratoplasty were markedly higher in patients older than 50 years than in younger patients, a study found. Cataract ...

Cataracts, which can have devastating effects on the eye, affect 42 percent of the population between the ages of 70 and 80, and 68 percent of the population over the age of 80, according to the ...

Cataracts are a leading cause of blindness worldwide, contributing to nearly half of all cases. According to the World Health Organization (WHO), cataracts affect approximately 65.2 million people ...

Researchers working to understand the biochemistry of cataract formation have made a surprising finding: A protein that was long believed to be inert actually has an important chemical function that ...

Researchers demonstrate that a finely tuned balance of attractions between proteins keeps the lens of the eye transparent, and that even a small change in this balance can cause proteins to aggregate, ...

A new drug being developed by Calpain Therapeutics in Australia can delay cataracts forming and slow cataract growth, according to an Institute of Photonics and Advanced Sensing report. The drug could ...

The most common cause of blindness worldwide is unoperated cataracts. For some, lack of access to quality cataract surgery has a strong role in the growing backlog of unoperated and untreated ...

Researchers working to understand the biochemistry of cataract formation have made a surprising finding: A protein that was long believed to be inert actually has an important chemical function that ...

It’s estimated more than 24 million Americans, age 40 and older, have cataracts. This painless clouding of the lens of the eye can cause serious problems. But cataracts can be easily treated, ...

Prospective, non-randomised, interventional cohort case series. A total of 27 eyes of 27 patients with diabetic macular oedema received an intravitreal injection of 4 mg (0.1 ml) of triamcinolone ...